A (Agilent Technologies, Inc.) Enterprise Value-to-Revenue Coefficient

Public company logo of agilent.com (A)

Agilent Technologies (A) automates laboratory processes by developing software and instruments for bioanalysis. This EV/Sales chart visualizes the market value of the business relative to sales excluding debt, where 7002.77 shows the current value of the metric. Growth depends on biotech center investments in equipment, while competition for budgets and low-cost tests forces the company to continuously innovate.

Agilent Technologies, Inc. - A Company Value to Revenue (period 11/23/2025 - 11/20/2026)

Agilent Corp - analytical breakdowns and key metrics (A)

- share price and consensus valuation forecast:
- business market valuation indicators:
Fundamental company valuation:agilent.com A
Core merchandise of Agilent Tech

Agilent Technologies (A) benefits from a consolidated analytical equipment market, where high switching costs protect the company's revenues. This enterprise value-to-revenue ratio combines market capitalization and net debt, allowing for an assessment of the real price of assets relative to the generated cash flow. The anomalous growth of this metric on the chart signals inflated market expectations, which increases the risk of overpaying for future growth rates.

Competitor analysis

Total Company Value-to-Revenue Ratio Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Company Value to Revenue|Company Value to Revenue Cologuard|RVTY (Revvity Corp) - EV/Sales Multiple|EV/Sales Multiple Bio-Rad Laboratories Inc|Company Value to Revenue NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Business Value to Revenue|Enterprise Value-to-Revenue Ratio QuidelOrtho Inc. QDEL|EV/Sales Multiple OPKO Health Inc OPK|CareDx Inc - EV/Sales Multiple|Business Value to Revenue MRVI (Maravai)|FLGT: EV/Sales Multiple|LAB (Standard BioTools Inc.) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Cytek Biosciences Inc|Enterprise Value-to-Revenue Multiple OraSure OSUR|Company Value to Revenue XGN (Exagen Diagnostics)|Total Company Value-to-Revenue Ratio MDxHealth Inc.|Enterprise Value-to-Revenue Ratio Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Enterprise Value-to-Revenue Multiple|Insight Molecular Diagnostics Inc - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple trinitybiotech.com|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue